[¼Ö·ç¿¥ ÇコÄɾî ​¼Ò½Ä]

📰 ​¼Ö·ç¿¥ÇコÄɾî ​½ÅÀÓ ´ëÇ¥À̻翡 ​±èÁöÈñ ¹Ú»ç (2025-02-03)

***-****-****7P" rel="noopener noreferrer" target="_blank" style="box-sizing: border-box; padding: 0px; margin: 0px; font-style: inherit; font-variant: inherit; font-stretch: inherit; font-size: inherit; line-height: inherit; font-family: inherit; font-optical-sizing: inherit; font-size-adjust: inherit; font-kerning: inherit; font-feature-settings: inherit; font-variation-settings: inherit; cursor: pointer;">https://www.hankyung.com/article/2***-****-****7P


ÁÖ¿ä¾÷¹«

• Clinical ​Trial ​Study Timeline ​Management: Discovery ÀÓ»ó ​¹× Ž»öÀÓ»ó ​ŸÀÓ¶óÀÎ ​Æȷξ÷

• CRO ​Communication: ​CRO ​¹× ±â°ü Ä¿¹Â´ÏÄÉÀ̼Ç

• ​IRB ​related activity: ü¿ÜÁø´ÜÀÇ·á±â±â ​Çã°¡¸¦ ​À§ÇÑ ​ÀÓ»ó IRB °ü¸®

• ​Essential document ​management: ​ÀÓ»ó½ÃÇè °èȹ, ​¼³°è, ¸ð´ÏÅ͸µ ​µî ​¹®¼­°ü¸®


ÀÚ°Ý ¿ä°Ç


Çʼö¿ª·®


¿ì´ë»çÇ×


±Ù¹«Áö

°æ±âµµ ¿ëÀνà ±âÈﱸ ¿ë±¸´ë·Î 2354, ¼Ö·ç¿¥ º»»ç


ä¿ëÀýÂ÷

• ¼­·ùÀüÇü > 1Â÷¸éÁ¢ > ·¹ÆÛ·±½º üũ(°æ·Â) > 2Â÷¸éÁ¢ > ÃÖÁ¾ÇÕ°Ý

** ¸éÁ¢ Áغñ ¹× Âü°¡¿¡ ´ëÇÑ °¨»çÀÇ Àǹ̷Î, ¼ÒÁ¤ÀÇ ¸éÁ¢ºñ¸¦ µå¸®°í ÀÖ½À´Ï´Ù.


±âŸ¾È³»

• Áö¿ø¼­´Â ä¿ë »çÀÌÆ® ¹× ¸®¸â¹ö¸¦ ÅëÇؼ­¸¸ Á¢¼öÇϸç À̸ÞÀÏ ¹× ¿ÀÇÁ¶óÀÎÀ» ÅëÇÑ °³º° Á¢¼ö´Â ¹ÞÁö ¾Ê½À´Ï´Ù.

• ÀÔ»çÁö¿ø¼­¿¡ ±âÀçÇÑ ³»¿ëÀÌ »ç½Ç°ú ´Ù¸£°Å³ª,Á¦Ãâ¼­·ù°¡ ÇãÀ§·Î ÆǸíµÉ °æ¿ì ¶Ç´Â °ü·Ã ¼­·ù ¹ÌÁ¦Ãâ½Ã ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

• »ó¼¼ÀÏÁ¤ ¹× Áõºù¼­·ù Á¦ÃâÀº °¢ ÀüÇüÀýÂ÷ ´Ü°èº°ÇÕ°ÝÀÚ¿¡ ÇÑÇÏ¿© °³º° °øÁöÇÒ ¿¹Á¤ÀÔ´Ï´Ù.

• ±¹°¡º¸ÈÆ´ë»óÀÚ ¹× ±¹°¡µî·ÏÀå¾ÖÀÎ µî Ãë¾÷º¸È£´ë»óÀÚ´Â °ü°è ¹ý·É¿¡ ÀÇ°Å ¿ì´ëÇÕ´Ï´Ù.

• Reference Check´Â °ü·Ã µ¿ÀǼ­ ÀÛ¼º ÈÄ ÁøÇàµÇ¸ç, °á°ú¿¡ µû¶ó ä¿ë ºÎÀû°Ý »çÀ¯°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.